Tolerability of Retreatment with Omalizumab, a Recombinant Humanized Monoclonal Anti-IgE Antibody, during a Second Ragweed Pollen Season in Patients with Seasonal Allergic Rhinitis

Author: Nayak Anjuli   Casale Thomas   Miller S. David   Condemi John   McAlary Margaret   Fowler-Taylor Angel   Della Cioppa Giovanni   Gupta Niroo  

Publisher: OceanSide Publications, Inc

ISSN: 1539-6304

Source: Allergy and Asthma Proceedings, Vol.24, Iss.5, 2003-09, pp. : 323-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content